Related Experiment Videos
[Peptostreptococcus magnus osteoarticular infections after orthopedic surgery. 14 cases and pathogenicity factors]
A Felten1, N Desplaces, R Nizard
1Service de Microbiologie, Hôpital Saint-Louis, Paris, France.
Abstract:
We report a retrospective study of 14 Peptostreptococcus magnus bone and joint infections, following orthopaedic prostheses or implantation of fixation devices, diagnosed in two Paris hospitals between 1992 and 1996. Five patients experienced a knee joint infection after anterior cruciate ligament reconstruction with 4 artificial grafts, and 9 caught joint or wound infections, after limb traumatic injuries or bone neoplastic ruptures involving femur, tibia, calcaneum and humerus, treated by arthroplasty or osteosynthesis with implantation of biomaterials. Septic arthritis was experienced one week to one year after reconstructive surgery, and had evolved for several months to years before etiologic diagnosis in 5 cases. Specimens of pus, tissues or removed implants produced numerous slow growing small colonies of Gram positive cocci arranged in clumps on culture media incubated in anaerobic atmosphere only. In 10 patients, the same organism was disclosed in several separate specimens. The identification of P. magnus was assessed by the enzyme profile (rapid ID 32A API strips), gaz liquid chromatography, catalase and coagulase production, resistance to novobiocin and Na polyanethol sulphonate. Antibiotic sensitivity testing performed by disc method was constant to penicillin G, amoxicillin, cefuroxime, cefoxitin, imipenem and pristinamycin with penicillin G MICs < 0.125 mg/l and metronidazole MICs < 1 mg/l. Erythromycin, clindamycin, rifampicin, tetracycline and fosfomycin were active against more than 70% of P. magnus. All patients were cured after a prolonged course of various antibiotics and surgical removal of the foreign material whenever possible. We studied in vitro binding of P. magnus with extracellular matrix proteins adsorbed onto biomaterials, by particle agglutination assays of latex beads coated with proteins. Eighty one% of strains bound to collagen, 69% to fibrinogen and 46% to fibronectin. Comparison of orthopaedic strains with strains of other infections and from skin showed a correlation between P. magnus from bone and joint infections and their fibrinogen binding ability (69% against 20%, p < 0.05).
Insights
Peptostreptococcus magnus bone and joint infections are linked to biomaterials. This study found P. magnus strains from these infections exhibit higher fibrinogen binding, aiding in diagnosis and treatment.
Area of Science:
- Clinical Microbiology
- Infectious Diseases
- Orthopaedic Surgery
Context:
- Retrospective study of 14 bone and joint infections caused by Peptostreptococcus magnus.
- Infections occurred post-orthopaedic prostheses or fixation device implantation.
- Cases diagnosed between 1992-1996 in Paris hospitals.
Purpose:
- To investigate the characteristics of P. magnus bone and joint infections.
- To identify potential virulence factors, such as extracellular matrix protein binding.
- To correlate bacterial properties with infection type.
Summary:
- P. magnus identified in bone and joint infections after surgery involving biomaterials.
- Bacterial identification confirmed via enzyme profiling and biochemical tests.
- Antibiotic sensitivity testing showed consistent susceptibility to penicillin G and metronidazole.
- In vitro studies revealed significant binding of P. magnus to collagen, fibrinogen, and fibronectin.
- Orthopaedic P. magnus strains showed a higher affinity for fibrinogen compared to other strains.
Impact:
- Findings suggest fibrinogen binding as a potential virulence factor for P. magnus in orthopaedic infections.
- Understanding bacterial-biomaterial interactions can inform strategies for preventing and treating these infections.
- Successful treatment involved prolonged antibiotic therapy and surgical removal of foreign material.